Inactive Instrument

Teva Pharmaceutical Industries Limited Stock price TEL AVIV STOCK EXCHANGE

Equities

IL0006290147

Pharmaceuticals

Sales 2024 * 15.86B 5,782B Sales 2025 * 16.28B 5,938B Capitalization 14.93B 5,445B
Net income 2024 * 420M 153B Net income 2025 * 743M 271B EV / Sales 2024 * 1.86 x
Net Debt 2024 * 14.62B 5,333B Net Debt 2025 * 12.12B 4,419B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18.4 x
P/E ratio 2025 *
14.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.57%
More Fundamentals * Assessed data
Dynamic Chart
JPMorgan Upgrades Teva Pharmaceutical Industries to Neutral From Underweight, Adjusts Price Target to $14 From $11 MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing MT
Global markets live: Domino's Pizza, Walt Disney, Broadcom, Ryanair, Exxon Mobil, Goldman Sachs... Our Logo
Alvotech, Teva Say Simlandi Receives US FDA Approval as Interchangeable Humira Biosimilar MT
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week MT
Teva Pharmaceutical's TEV-'574 Antibody Found to Be Safe in Studies MT
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO RE
Teva Pharmaceutical Shares Rise After Piper Sandler Upgrade MT
Piper Sandler Upgrades Teva Pharmaceutical Industries to Overweight From Neutral, Adjusts PT to $19 From $12 MT
High-dose opioid reversal spray no better than lower dose in field, US study finds RE
More news

Latest transcript on Teva Pharmaceutical Industries Limited

Managers TitleAgeSince
Chief Executive Officer 55 22-12-31
Director of Finance/CFO 51 19-12-21
Chief Tech/Sci/R&D Officer - 22-07-31
Members of the board TitleAgeSince
Director/Board Member 77 15-08-31
Director/Board Member 60 20-06-08
Chairman 76 14-12-31
More insiders
Teva Pharmaceutical Industries Limited is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
More about the company
  1. Stock
  2. Equities
  3. Stock Teva Pharmaceutical Industries Limited
  4. Stock Teva Pharmaceutical Industries Limited - TEL AVIV STOCK EXCHANGE